Session Chair Profile

M.D., Chief of Cardiology, Zuckerberg San Francisco General Hospital; Maurice Eliaser Distinguished Professor of Medicine, UCSF

Dr. Peter Ganz is the Chief of Cardiology at the Zuckerberg San Francisco General Hospital and Maurice Eliaser Distinguished Professor at UCSF. Dr. Ganz has been a pioneer in translational cardiovascular research. He was the first to publish on vascular endothelial function in health and its dysfunction in atherosclerosis in humans (N Engl J Med 1986; 315:1046-1051). Currently, Dr. Ganz is making important discoveries in the field of proteomics, using modified aptamers as binding reagents to quantify proteins in blood (JAMA 2016;315:2532-2541). Relevant to his presentation, he is improving assessment of drug safety through proteomics ( Dr. Ganz received his M.D. from Harvard, completed his residency at the Massachusetts General Hospital and cardiovascular fellowship at the Brigham and Women’s Hospital. He spent 25 years directing cardiovascular research in the cardiac catheterization laboratories at the Brigham and Women’s Hospital and Harvard Medical School, prior to arriving to UCSF in 2008.

Session Abstract – PMWC 2019 Silicon Valley

Session Synopsis: The integration of multiple ‘omics’ technologies will allow us to gain a more complete picture of the constituents and mechanisms of various diseases including cardiovascular disease. This session will touch upon various “omics” technologies – genomics, transcriptomics, proteomics, and microbiomics – and their applications to uncover the complexity in cardiovascular disease mechanism and progression.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

You have Successfully Subscribed!